CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $3.37 ($33,700)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $3.98 ($79,600)
- 8-K Event Executive or director change
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $3.86 ($77,200)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 19 · 362 filings